肝素诱导的血小板缺血:一个插图的回顾
Jori May1, Brian Westbrook1, Adam Cuker2,3
1Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Research and practice in thrombosis and haemostasis
|August 21, 2023
概括
氨酸诱导的血小板缺血 (HIT) 是对氨酸的免疫反应,导致血小板和血栓的低水平. 4Ts评分有助于识别需要进一步评估和治疗的患者.
科学领域:
- 内部医学 内部医学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 肝素诱导的血小板缺血 (HIT) 是一种严重的免疫媒介药物不良反应.
- 它涉及对血小板因子4和肝素的抗体,导致血小板缺血和血栓形成.
- 在住院患者中,由于频繁使用肝素,HIT是引起重大关注的.
研究的目的:
- 提供HIT诊断和管理的视觉总结.
- 将HIT病理生理学与临床实践和质量改进联系起来.
- 突出诊断和管理陷和基于证据的护理的珍珠.
主要方法:
- 使用4Ts评分来评估患者的HIT概率.
- 推免疫试验和功能试验以确认HIT.
- 审查用于HIT管理的肝素避免和非肝素抗凝药.
主要成果:
- 4Ts评分有助于识别患有增加HIT概率的患者.
- 诊断试验对于确认中等至高风险患者的HIT至关重要.
- 有效的HIT管理包括停止肝素和替代性抗凝药.
结论:
- 准确的HIT诊断和及时的治疗对于预防血栓形成至关重要.
- 了解HIT病理生理学有助于临床决策和质量改进.
- 本综述为管理HIT提供了视觉辅助和实际指导,包括心肺绕道和自身免疫亚型等特殊病例.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
751
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
Disorders of Hemostasis
989
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
989
Introduction to Hemostasis
8.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K


